CEO of Devicare
Apr 20 / 2018
Sala Polivalent · UAB Research Park
The case of Devicare, developer of innovative solutions for diagnosis, prognosis, treatment and monitoring of chronic diseases, and its collaboration with the Group of Chemical Transducers (GTQ) of the IMB-CNM (CSIC), which develops new biochemical transducers based on different materials and interaction methods.
The impressive advances in medical science over the last few years are associated with technological breakthroughs in other fields of research. This is particularly evident in the innovations taking place in the area of sensors.
A recent report by Frost & Sullivan on emerging sensor technologies for medical diagnostics points out that, in the field of research, the main breakthroughs are taking place in the fields of nanotechnology, microelectronics and advanced materials.
In this context, health sensor tendencies involve nanotechnology, robotics, and three-dimensional (3D) printing, ICT, smart devices and virtual reality. The current outlook also shows an interesting confluence and synergy between research approaches.
Speakers
Rosendo Garganta
Antoni Baldi
Scientist of the GTQ of the Microelectronic Institute of Barcelona (IMB-CNM) of the CSIC